Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52


The Development of the Study of Hereditary Cancer in South America.

Rossi BM, Sarroca C, Vaccaro C, Lopez F, Ashton-Prolla P, Ferreira Fde O, Santos EM.

Genet Mol Biol. 2016 May 24;39(2):166-7. doi: 10.1590/1678-4685-GMB-2014-0366. No abstract available.


A proposed staging system and stage-specific interventions for familial adenomatous polyposis.

Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, Bülow S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G.

Gastrointest Endosc. 2016 Jul;84(1):115-125.e4. doi: 10.1016/j.gie.2015.12.029. Epub 2016 Jan 6.


Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.

Villacis RA, Miranda PM, Gomy I, Santos EM, Carraro DM, Achatz MI, Rossi BM, Rogatto SR.

Int J Cancer. 2016 Apr 15;138(8):1928-35. doi: 10.1002/ijc.29948. Epub 2015 Dec 28.


Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.

Carneiro da Silva F, Ferreira JR, Torrezan GT, Figueiredo MC, Santos ÉM, Nakagawa WT, Brianese RC, Petrolini de Oliveira L, Begnani MD, Aguiar-Junior S, Rossi BM, Ferreira Fde O, Carraro DM.

PLoS One. 2015 Oct 5;10(10):e0139753. doi: 10.1371/journal.pone.0139753. eCollection 2015.


ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients.

Villacis RA, Abreu FB, Miranda PM, Domingues MA, Carraro DM, Santos EM, Andrade VP, Rossi BM, Achatz MI, Rogatto SR.

Tumour Biol. 2016 Mar;37(3):3145-53. doi: 10.1007/s13277-015-4145-0. Epub 2015 Oct 1.


Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.

Paiva TF Jr, de Jesus VH, Marques RA, da Costa AA, de Macedo MP, Peresi PM, Damascena A, Rossi BM, Begnami MD, de Lima VC.

BMC Cancer. 2015 Sep 22;15:643. doi: 10.1186/s12885-015-1648-4.


Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.

Silva FC, Lisboa BC, Figueiredo MC, Torrezan GT, Santos EM, Krepischi AC, Rossi BM, Achatz MI, Carraro DM.

BMC Med Genet. 2014 May 15;15:55. doi: 10.1186/1471-2350-15-55.


Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.

De Oliveira LP, López I, Dos Santos EM, Tucci P, Marín M, Soares FA, Rossi BM, Coudry Rde A.

Oncol Rep. 2014 Mar;31(3):1396-406. doi: 10.3892/or.2013.2940. Epub 2013 Dec 20.


Mutation spectrum in South American Lynch syndrome families.

Dominguez-Valentin M, Nilbert M, Wernhoff P, López-Köstner F, Vaccaro C, Sarroca C, Palmero EI, Giraldo A, Ashton-Prolla P, Alvarez K, Ferro A, Neffa F, Caris J, Carraro DM, Rossi BM.

Hered Cancer Clin Pract. 2013 Dec 18;11(1):18. doi: 10.1186/1897-4287-11-18.


Mutational spectrum of the APC and MUTYH genes and genotype-phenotype correlations in Brazilian FAP, AFAP, and MAP patients.

Torrezan GT, da Silva FC, Santos EM, Krepischi AC, Achatz MI, Aguiar S Jr, Rossi BM, Carraro DM.

Orphanet J Rare Dis. 2013 Apr 5;8:54. doi: 10.1186/1750-1172-8-54.


Hereditary colorectal cancer and Lynch syndrome.

Rossi BM.

BMC Proc. 2013 Apr 4;7 Suppl 2:K2. doi: 10.1186/1753-6561-7-S2-K2. eCollection 2013. No abstract available.


Evaluation of MLH1 I219V polymorphism in unrelated South American individuals suspected of having Lynch syndrome.

Valentin MD, Da Silva FC, Santos EM, Da Silva SD, De Oliveira Ferreira F, Aguiar Junior S, Gomy I, Vaccaro C, Redal MA, Della Valle A, Sarroca C, Rasmussen LJ, Carraro DM, Rossi BM.

Anticancer Res. 2012 Oct;32(10):4347-51.


Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries.

Monteiro Santos EM, Valentin MD, Carneiro F, de Oliveira LP, de Oliveira Ferreira F, Junior SA, Nakagawa WT, Gomy I, de Faria Ferraz VE, da Silva Junior WA, Carraro DM, Rossi BM.

BMC Cancer. 2012 Feb 9;12:64. doi: 10.1186/1471-2407-12-64.


Breakpoint characterization of a novel large intragenic deletion of MUTYH detected in a MAP patient: case report.

Torrezan GT, da Silva FC, Krepischi AC, Santos ÉM, Ferreira Fde O, Rossi BM, Carraro DM.

BMC Med Genet. 2011 Sep 30;12:128. doi: 10.1186/1471-2350-12-128.


Risk perception among Brazilian individuals with high risk for colorectal cancer and colonoscopy.

Santos EM, Lourenço MT, Rossi BM.

Hered Cancer Clin Pract. 2011 Jul 28;9:4. doi: 10.1186/1897-4287-9-4.


Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.

Valentin MD, da Silva FC, dos Santos EM, Lisboa BG, de Oliveira LP, Ferreira Fde O, Gomy I, Nakagawa WT, Aguiar Junior S, Redal M, Vaccaro C, Valle AD, Sarroca C, Carraro DM, Rossi BM.

Fam Cancer. 2011 Dec;10(4):641-7. doi: 10.1007/s10689-011-9461-y.


Ezrin expression as a prognostic marker in colorectal adenocarcinoma.

Patara M, Santos EM, Coudry Rde A, Soares FA, Ferreira FO, Rossi BM.

Pathol Oncol Res. 2011 Dec;17(4):827-33. doi: 10.1007/s12253-011-9389-4. Epub 2011 Apr 5.


Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST.

de Azevedo CR, Paiva TF Jr, Rossi BM, Guimarães GC, de Souza Begnami MD, Oliveira TB, Barros E Silva MJ, Fanelli MF, de Mello CA.

Int J Clin Oncol. 2011 Jun;16(3):279-83. doi: 10.1007/s10147-010-0133-y. Epub 2010 Oct 5.


Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.

da Silva FC, de Oliveira LP, Santos EM, Nakagawa WT, Aguiar Junior S, Valentin MD, Rossi BM, de Oliveira Ferreira F.

Fam Cancer. 2010 Dec;9(4):563-70. doi: 10.1007/s10689-010-9373-2.


Supplemental Content

Loading ...
Support Center